Research led by internist-nephrologist Dr. Michele Eisenga shows that SGLT2 inhibitors, a class of drugs widely used to treat type 2 diabetes, heart failure and chronic kidney disease, consistently increase hemoglobin and hematocrit levels.
Related Posts
Weeds or Medicine? What Our Elders Knew About Mental Health
I was a child the first time my grandmother sent me to a field near our apartment in Pittsburgh. It was not a cute, manicured […]
Mindfulness and self-compassion can alleviate premenstrual symptoms
Credit: Pixabay/CC0 Public Domain A kind attitude toward oneself and practicing mindfulness can improve functioning in individuals who experience severe premenstrual symptoms, according to a […]
DNA from centuries-old skeletons buried in Montreal exposes no hereditary mixing between Indigenous individuals and French colonists
Old DNA from skeletons hidden in a historic cemetery in Quebec is altering individuals’s understanding of their Indigenous ancestry. In contrast to popular belief, there […]